Substituting BCNU by thiotepa in the conditioning regimen of patients with lymphomas undergoing an autologous stem cell transplantation (team protocol). The experience of one centre

被引：0
|
作者：
Maw, D. [1 ]
Jansen, A. [1 ]
Sims, H. [1 ]
Crawley, C. [1 ]
Sureda, A. [1 ]
机构：
[1] Addenbrookes Hosp, Cambridge, England
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [31] Thiotepa 10 mg/kg Treatment Regimen Is Superior to Thiotepa 5 mg/kg in TBF Conditioning in Patients Undergoing Allogeneic Stem-Cell Transplantation
    El-Cheikh, Jean
    Massoud, Radwan
    Moukalled, Nour
    Haffar, Basel
    Assi, Hazem
    Zahreddine, Ammar
    Mahfouz, Rami
    Bazarbachi, Ali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (05): : 368 - 374
  • [32] Autologous Hematopotoietic Stem Cell Transplantation in Multiple Sclerosis with An Intermediate Intensity Conditioning Regimen: The Italian Multi-Centre Experience
    Saccardi, Riccardo
    Sormani, MariaPia
    Di Gioia, Massimo
    Bosi, Alberto
    Cuneo, Antonio
    Majolino, Ignazio
    Cavanna, Luigi
    Ciceri, Fabio
    Papineschi, Federico
    Mangoni, Marcellina
    La Nasa, Giorgio
    Pini, Massimo
    Guerrasio, Angelo
    Onida, Francesco
    Gualandi, Francesca
    Irrera, Giuseppe
    Di Bartolomeo, Paolo
    Donelli, Amedea
    Gugliotta, Luigi
    Vuolo, Luisa
    Mancardi, Gianluigi
    BLOOD, 2011, 118 (21) : 157 - 158
  • [33] Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
    Mancardi, G. L.
    Sormani, M. P.
    Di Gioia, M.
    Vuolo, L.
    Gualandi, F.
    Amato, M. P.
    Capello, E.
    Curro, D.
    Uccelli, A.
    Bertolotto, A.
    Gasperini, C.
    Lugaresi, A.
    Merelli, E.
    Meucci, G.
    Motti, L.
    Tola, M. R.
    Scarpini, E.
    Repice, A. M.
    Massacesi, L.
    Saccardi, R.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (06) : 835 - 842
  • [34] A novel conditioning regimen or thiotepa, melphalan, and cyclophosphamide for autologous stem cell transplantation (ASCT) in chemosensitive multiple myeloma.
    Venigalla, M
    Azar, D
    Becker, P
    Emmons, R
    Westervelt, P
    Hsieh, CC
    Qin, L
    Ballen, K
    BLOOD, 2002, 100 (11) : 436A - 436A
  • [35] Autologous haematopoietic stem cell transplantation with thiotepa-cyclophosphamide conditioning in aggressive multiple sclerosis: clinical experience in eight patients
    Moiola, L.
    Comi, G.
    Radaelli, M.
    Martinelli, V.
    Rossi, P.
    Rovaris, M.
    Martino, G.
    Roccia, T.
    Peccattori, J.
    Ciceri, F.
    MULTIPLE SCLEROSIS, 2007, 13 : S247 - S247
  • [36] Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
    Fujimaki, K
    Taguchi, J
    Fujita, H
    Hattori, M
    Yamazaki, E
    Takahashi, N
    Fujisawa, S
    Kanamori, H
    Maruta, A
    Ishigatsubo, Y
    BONE MARROW TRANSPLANTATION, 2004, 33 (08) : 789 - 792
  • [37] New non-myeloablative conditioning regimen for multiple sclerosis patients undergoing autologous hematopoietic stem cell transplantation
    Novik, Andrei A.
    Kuznetsov, Alexey N.
    Melnichenko, Vladimir Y.
    Fedorenko, Denis A.
    Ionova, Tatiana L.
    Kruglina, Ruslana V.
    Kartashov, Andrei V.
    Gorodokin, Gary J.
    MULTIPLE SCLEROSIS, 2008, 14 : S169 - S169
  • [38] Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
    K Fujimaki
    J Taguchi
    H Fujita
    M Hattori
    E Yamazaki
    N Takahashi
    S Fujisawa
    H Kanamori
    A Maruta
    Y Ishigatsubo
    Bone Marrow Transplantation, 2004, 33 : 789 - 792
  • [39] Bendamustine as an alternative to BCNU as conditioning regimen for autologous stem cell transplantation in patients with aggressive lymphoma: Results phase 2 study from GELTAMO
    Maria Redondo, Alba
    Valcarcel, D.
    Gonzalez, A. P.
    Suarez-Lledo, M.
    Bello, J. L.
    Canales, M.
    Gayoso, J.
    Conde, E.
    Jarque, I.
    Del Campo, R.
    Arranz, R.
    Terol, M. J.
    Rifon, J. J.
    Rodriguez, M. J.
    Ramirez, M. J.
    Castro, N.
    Sanchez, A.
    Lopez-Jimenez, J.
    Briones, J.
    Lopez, A.
    Palomera, L.
    Baile, M.
    Caballero, Dolores
    Martin, Alejandro
    BONE MARROW TRANSPLANTATION, 2018, 53 : 261 - 262
  • [40] First remission autologous stem cell transplantation (ASCT) with BCNU/thiotepa shows good response in patients with CNS lymphoma
    Khan, A. B.
    Atwal, S.
    Devereux, S.
    Potter, V.
    Pagliuca, A.
    Marcus, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 85 - 86
12345